| Pseudomonas aeruginosa (SOUTHCENTRAL Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| ceftazidime | 84.2% n=310 | 82.8% n=58 | |||||
| cefepime | 85.5% n=310 | 74.1% n=58 | |||||
| ciprofloxacin | 72.9% n=310 | 58.6% n=58 | |||||
| levofloxacin | 73.2% n=310 | 58.6% n=58 | |||||
| gentamicin | 87.4% n=310 | 79.3% n=58 | |||||
| tobramycin | 93.2% n=310 | 96.6% n=58 | |||||
| amikacin | 94.3% n=194 | ||||||
| aztreonam | 75.6% n=78 | ||||||
| imipenem | 88.1% n=310 | 93.1% n=58 | |||||
| piperacillin | 90.8% n=195 | ||||||
| pip/taz | 92.3% n=310 | 93.1% n=58 | |||||
| Totals | 85.4% n=2947 | 79.5% n=464 | |||||
This data is accurate as of: 11/22/2016 11:54:09 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: aztreonam, ceftazidime, cefepime, ciprofloxacin, levofloxacin, gentamicin, tobramycin, imipenem, pip/taz.
